SUN VALLEY, CA--(Marketwire - July 22, 2008) - XTend Medical Corporation (PINKSHEETS: XMDC), a company that delivers cutting-edge telemedicine solutions to the healthcare industry, announced today the company will begin a telemedicine program in Europe to track the remote monitoring of diabetic patients in early August. According to Frost and Sullivan the European market is expected to hit $236 Million by 2014.
